Testicular Cancer - Results from #40

miR-371a-3p Predicting Viable Tumor in Patients Undergoing RPLND for Metastatic Testicular Cancer: The SWENOTECA-MIR Study. July 31, 2024

SEOM-GG clinical guidelines for the management of germ-cell testicular cancer (2023). July 29, 2024

Optimal imaging techniques across the spectrum of testicular cancer. July 29, 2024

RAISN: Robot-assisted Indocyanine Green-guided Sentinel Node Biopsy in Clinical Stage I Germ Cell Tumor. July 26, 2024

Pseudoephedrine for ejaculatory dysfunction after retroperitoneal lymph node dissection in testicular cancer. July 25, 2024

Low-cord orchidectomy for testicular cancer: what would be different? July 23, 2024

The experience of fertility concerns in patients with testicular cancer: a qualitative study. July 22, 2024

Discordance of retroperitoneal and thoracic histologic findings in patients with metastatic germ cell tumors at postchemotherapy residual tumor resection. July 19, 2024

Vascular fingerprint tool to identify patients with testicular cancer treated with cisplatin-based chemotherapy at high risk of early cardiovascular events. July 17, 2024

Effects of Chemotherapy on Aneuploidy Rates in Sperm from Male Patients with Testicular Cancer or Hodgkin's Lymphoma-A Systematic Review. July 15, 2024

Primary retroperitoneal lymph node dissection for metastatic non-seminomatous germ cell tumours: outcomes and adjuvant chemotherapy. July 12, 2024

Primary Retroperitoneal Lymph Node Dissection as Treatment for Low-volume Metastatic Seminoma in a Population-based Cohort: The Swedish Norwegian Testicular Cancer Group Experience. July 8, 2024

Survival of stage III non-seminoma testis cancer patients versus simulated controls, according to race/ethnicity. July 8, 2024

Contemporary Role of Radiation Therapy in Testicular Cancer. July 4, 2024

MicroRNA for Prediction of Teratoma and Viable Germ Cell Tumor after Chemotherapy. July 3, 2024

Unilateral Post-Chemotherapy Robot-Assisted Retroperitoneal Lymph Node Dissection for Stage II Non-Seminomatous Germ Cell Tumors: Sexual and Reproductive Outcomes. July 1, 2024

Testicular Cancer Survivorship and Fertility Preservation. July 1, 2024

Regionalization of Testis Cancer Care-Is It Necessary? July 1, 2024

Germ Cell Tumor of the Testis: Lethal Subtypes of a Curable Cancer. June 28, 2024

A Multicenter Evaluation of Treatment-Associated Changes in Body Composition in Men with Germ Cell Tumors (GCT) of the Testis: Implications for Adverse Events and Complications. June 24, 2024

Page 3 of 94